Healthcare Economist August 6, 2024
Perhaps not. At least that is according to a paper by Anderson et al. (2024). The authors use a difference-in-difference approach with 2018-2021 claims data. A summary of the results are below.
Approximately one-quarter of patients who use insulin report underuse because of cost. In response, more than twenty states have implemented monthly caps on insulin out-of-pocket spending, ranging from $25 to $100…
State-level caps on insulin out-of-pocket spending for commercial enrollees did not significantly increase insulin use; that may be in part...